Evolutionary trajectory of bacterial resistance to antibiotics and antimicrobial peptides in Escherichia coli
mSystems · 18.03.2025 · 10 (3)
DOI: 10.1128/msystems.01700-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSystems, erschienen am 18.03.2025. Verfasst von Feiyu Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzho…. Hauptthemen laut MEDLINE: Escherichia coli, Anti-Bacterial Agents, Drug Resistance, Bacterial, Antimicrobial Peptides. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
The global crisis of antimicrobial resistance poses a major threat to human health, underscoring the urgency of developing new antibacterial strategies. Antimicrobial peptides (AMPs) are promising alternatives to antibiotic therapy, yet potential microbial resistance is of great concern. Resistance is often accompanied by fitness costs, which may in turn influence the spread of drug-resistant bacteria and their susceptibility to other antimicrobial agents. Herein, we investigate the evolutionary trajectory of bacterial resistance to antibiotics and AMPs in Escherichia coli , and evaluate the fitness costs and collateral sensitivity of drug-resistant strains. We reveal that E. coli develops resistance to antibiotics, particularly ciprofloxacin and kanamycin, at a notably faster rate than to AMPs. Moreover, antibiotic-evolved strains exhibit slightly higher fitness costs than AMP-evolved bacteria, primarily manifested in reduced bacterial growth and swimming motility. Notably, we demonstrate that trimethoprim-resistant E. coli, with mutations in thyA gene, displays enhanced susceptibility to pexiganan, as evidenced by both in vitro and in vivo studies. Overall, our findings shed new insights for the clinical deployment of AMPs and propose innovative therapeutic strategies for combating antibiotic-resistant bacterial infections. IMPORTANCE The global spread of antimicrobial resistance necessitates the development of innovative anti-infective strategies. Antimicrobial peptides (AMPs) represent promising alternatives in the post-antibiotic era. By monitoring the evolutionary trajectory of bacterial resistance to eight antibiotics and ten AMPs in Escherichia coli , we demonstrate that E. coli exhibits slower emergence of resistance against AMPs compared with antibiotics. Additionally, these antibiotic-resistant strains incur significant fitness costs, particularly in bacterial growth and motility. Most importantly, we find that some antibiotic-resistant strains show collateral sensitivity to specific AMPs in both in vitro and animal infection models, which is conducive to accelerating the development of AMP-based antibacterial treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
- Joint International Research Laboratory of Agriculture and Agri-Product Safety, The Ministry of Education of China, Yangzhou University, Yangzhou, China.
- Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
ORCID-Profile: Feiyu Yu, Zhiqiang Wang, Yuan Liu
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Yu, F., Wang, D., Zhang, H., Wang, Z., & Liu, Y. (2025). Evolutionary trajectory of bacterial resistance to antibiotics and antimicrobial peptides in Escherichia coli. mSystems, 10(3). https://doi.org/10.1128/msystems.01700-24
Vancouver
Yu F, Wang D, Zhang H, Wang Z, Liu Y. Evolutionary trajectory of bacterial resistance to antibiotics and antimicrobial peptides in Escherichia coli. mSystems. 2025;10(3). doi:10.1128/msystems.01700-24
BibTeX
@article{Yu2025,
author = {Yu, Feiyu and Wang, Dejuan and Zhang, Haijie and Wang, Zhiqiang and Liu, Yuan},
title = {Evolutionary trajectory of bacterial resistance to antibiotics and antimicrobial peptides in Escherichia coli},
journal = {mSystems},
year = {2025},
volume = {10},
number = {3},
doi = {10.1128/msystems.01700-24}
}
EUVIMED